386 related articles for article (PubMed ID: 26666336)
21. Predictors of De Novo Nonalcoholic Fatty Liver Disease After Liver Transplantation and Associated Fibrosis.
Galvin Z; Rajakumar R; Chen E; Adeyi O; Selzner M; Grant D; Sapisochin G; Greig P; Cattral M; McGilvray I; Ghanekar A; Selzner N; Lilly L; Patel K; Bhat M
Liver Transpl; 2019 Jan; 25(1):56-67. PubMed ID: 30609189
[TBL] [Abstract][Full Text] [Related]
22. Characteristics and risk factors for recurrence of nonalcoholic steatohepatitis following liver transplantation.
Tokodai K; Karadagi A; Kjaernet F; Romano A; Ericzon BG; Nowak G
Scand J Gastroenterol; 2019 Feb; 54(2):233-239. PubMed ID: 30999770
[TBL] [Abstract][Full Text] [Related]
23. Non-alcoholic fatty liver disease after liver transplantation in patients with non-alcoholic steatohepatitis and cryptogenic cirrhosis: the impact of pre-transplant graft steatosis.
Eshraghian A; Nikeghbalian S; Kazemi K; Shamsaeefar A; Geramizadeh B; Malek-Hosseini SA
HPB (Oxford); 2020 Apr; 22(4):521-528. PubMed ID: 31431413
[TBL] [Abstract][Full Text] [Related]
24. High incidence of hepatocellular carcinoma and postoperative complications in patients with nonalcoholic steatohepatitis as a primary indication for deceased liver transplantation.
Kern B; Feurstein B; Fritz J; Fabritius C; Sucher R; Graziadei I; Bale R; Tilg H; Zoller H; Newsome P; Eschertzhuber S; Margreiter R; Öfner D; Schneeberger S
Eur J Gastroenterol Hepatol; 2019 Feb; 31(2):205-210. PubMed ID: 30320609
[TBL] [Abstract][Full Text] [Related]
25. Non-alcoholic fatty liver disease and liver transplantation.
Khan RS; Newsome PN
Metabolism; 2016 Aug; 65(8):1208-23. PubMed ID: 26997540
[TBL] [Abstract][Full Text] [Related]
26. [Prevalence and clinical features of non-alcoholic steatohepatitis in a hypertensive population].
García-Carretero R; Barquero-Pérez O; Mora-Jiménez I; Soguero-Ruiz C; Goya-Esteban R; Rodríguez-Castro C; Ramos-López J
Hipertens Riesgo Vasc; 2019; 36(3):130-136. PubMed ID: 30655210
[TBL] [Abstract][Full Text] [Related]
27. Frequency of Cardiovascular Events and Effect on Survival in Liver Transplant Recipients for Cirrhosis Due to Alcoholic or Nonalcoholic Steatohepatitis.
Piazza NA; Singal AK
Exp Clin Transplant; 2016 Feb; 14(1):79-85. PubMed ID: 26581602
[TBL] [Abstract][Full Text] [Related]
28. Is cryptogenic cirrhosis different from NASH cirrhosis?
Thuluvath PJ; Kantsevoy S; Thuluvath AJ; Savva Y
J Hepatol; 2018 Mar; 68(3):519-525. PubMed ID: 29162389
[TBL] [Abstract][Full Text] [Related]
29. Impact of obesity and diabetes on waitlist survival, probability of liver transplantation and post-transplant survival among chronic hepatitis C virus patients.
Aguilar M; Liu B; Holt EW; Bhuket T; Wong RJ
Liver Int; 2016 Aug; 36(8):1167-75. PubMed ID: 26858016
[TBL] [Abstract][Full Text] [Related]
30. Recurrent or De Novo Allograft Steatosis and Long-term Outcomes After Liver Transplantation.
Narayanan P; Mara K; Izzy M; Dierkhising R; Heimbach J; Allen AM; Watt KD
Transplantation; 2019 Jan; 103(1):e14-e21. PubMed ID: 29994981
[TBL] [Abstract][Full Text] [Related]
31. De-novo nonalcoholic steatohepatitis is associated with long-term increased mortality in liver transplant recipients.
Gitto S; de Maria N; di Benedetto F; Tarantino G; Serra V; Maroni L; Cescon M; Pinna AD; Schepis F; Andreone P; Villa E
Eur J Gastroenterol Hepatol; 2018 Jul; 30(7):766-773. PubMed ID: 29505475
[TBL] [Abstract][Full Text] [Related]
32. Evidence of bias during liver transplant evaluation of non-alcoholic steatohepatitis cirrhosis patients.
Danford CJ; Iriana S; Shen C; Curry MP; Lai M
Liver Int; 2019 Jun; 39(6):1165-1173. PubMed ID: 30809932
[TBL] [Abstract][Full Text] [Related]
33. Metabolic factors affecting hepatocellular carcinoma in steatohepatitis.
Zarrinpar A; Faltermeier CM; Agopian VG; Naini BV; Harlander-Locke MP; Kaldas FM; Farmer DG; Busuttil RW
Liver Int; 2019 Mar; 39(3):531-539. PubMed ID: 30427105
[TBL] [Abstract][Full Text] [Related]
34. De Novo and Recurrence of Nonalcoholic Steatohepatitis After Liver Transplantation.
Kappus M; Abdelmalek M
Clin Liver Dis; 2017 May; 21(2):321-335. PubMed ID: 28364816
[TBL] [Abstract][Full Text] [Related]
35. Impact of Nonmalignant Portal Vein Thrombosis in Transplant Recipients With Nonalcoholic Steatohepatitis.
Agbim U; Jiang Y; Kedia SK; Singal AK; Ahmed A; Bhamidimarri KR; Bernstein DE; Harrison SA; Younossi ZM; Satapathy SK
Liver Transpl; 2019 Jan; 25(1):68-78. PubMed ID: 30091296
[TBL] [Abstract][Full Text] [Related]
36. Treatment and survival of non-alcoholic steatohepatitis associated hepatocellular carcinoma.
Weinmann A; Alt Y; Koch S; Nelles C; Düber C; Lang H; Otto G; Zimmermann T; Marquardt JU; Galle PR; Wörns MA; Schattenberg JM
BMC Cancer; 2015 Apr; 15():210. PubMed ID: 25884354
[TBL] [Abstract][Full Text] [Related]
37. Post-transplant diabetes mellitus and preexisting liver disease - a bidirectional relationship affecting treatment and management.
Cigrovski Berkovic M; Virovic-Jukic L; Bilic-Curcic I; Mrzljak A
World J Gastroenterol; 2020 Jun; 26(21):2740-2757. PubMed ID: 32550751
[TBL] [Abstract][Full Text] [Related]
38. Increased Risk of Death in First Year After Liver Transplantation Among Patients With Nonalcoholic Steatohepatitis vs Liver Disease of Other Etiologies.
Nagai S; Collins K; Chau LC; Safwan M; Rizzari M; Yoshida A; Abouljoud MS; Moonka D
Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2759-2768.e5. PubMed ID: 31004758
[TBL] [Abstract][Full Text] [Related]
39. Non-alcoholic fatty liver disease following liver transplantation: a clinical review.
Merola J; Liapakis A; Mulligan DC; Yoo PS
Clin Transplant; 2015 Sep; 29(9):728-37. PubMed ID: 26147308
[TBL] [Abstract][Full Text] [Related]
40. Nonalcoholic Steatohepatitis is the Most Rapidly Growing Indication for Simultaneous Liver Kidney Transplantation in the United States.
Singal AK; Hasanin M; Kaif M; Wiesner R; Kuo YF
Transplantation; 2016 Mar; 100(3):607-12. PubMed ID: 26479282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
